mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
7e-08 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-08 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.003 |